Related Experiment Video
Updated: Oct 12, 2025

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
HNRNPA2B1 as a trigger of RNA switch modulates the miRNA-mediated regulation of CDK6
Menghui Yin1,2, Meidie Cheng1,2, Chengli Liu1
1State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Guangzhou, Guangdong 510530, China.
Abstract:
The functional inactivation of tumor suppressor microRNA (miRNA) is closely related to the tumorigenesis of cancer. There are instances where the miRNA and the corresponding target both exist in a cell, but the target gene silencing do not occur as expected. Herein, we found that both miR-506 and its target CDK6 are highly co-expressed in lung cancer cells. Sequence analyses suggested that a miR-506 binding site (1648-1654) and a cis-element (1785-1795) for binding by heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) are evolutionarily conserved and forms a stem structure in the 3' untranslated region (3'UTR) of CDK6. Furthermore, HNRNPA2B1 can bind to the stem structure to denature it and recruit the RNA helicase DExH-box helicase 9 (DHX9) to the 3'UTR, which ultimately facilitates miRNAs-mediated CDK6 silencing. These results indicate that the cis-element of the 3'UTR of CDK6, where HNRNPA2B1 binds, serves as an RNA switch to regulate miRNAs' function in cancer cells.
Insights
In lung cancer, heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1) and DExH-box helicase 9 (DHX9) bind the CDK6 3'UTR. This interaction regulates microRNA-506 (miRNA-506) function, impacting tumor suppressor activity.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- MicroRNA (miRNA) inactivation is linked to cancer development.
- Sometimes, miRNA and target genes coexist without expected gene silencing.
Purpose of the Study:
- Investigate the mechanism behind miR-506 and CDK6 co-expression in lung cancer.
- Determine the role of regulatory elements in the CDK6 3'UTR in miRNA-mediated silencing.
Main Methods:
- Sequence analysis of the CDK6 3'UTR.
- Investigated binding of HNRNPA2B1 and DHX9.
- Assessed miRNA-mediated gene silencing.
Main Results:
- miR-506 and its target CDK6 are co-expressed in lung cancer.
- A conserved stem structure in the CDK6 3'UTR binds HNRNPA2B1.
- HNRNPA2B1 recruits DHX9, facilitating miR-506-mediated CDK6 silencing.
Conclusions:
- HNRNPA2B1 binding to the CDK6 3'UTR acts as an RNA switch.
- This switch regulates miRNA function in cancer cells, impacting tumor suppressor activity.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Polymerase II Accessory Proteins
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Translational Regulation
Experimental RNAi
Regulation of Expression at Multiple Steps

